In This Article:
The Canadian market is navigating a period of uncertainty, with looming tariffs and political shifts contributing to a cautious investment climate. Despite these challenges, opportunities remain for investors willing to explore lesser-known areas of the market. Penny stocks, though an older term, still represent potential growth avenues in smaller or newer companies when backed by solid financial health. In this article, we'll examine three such penny stocks that stand out for their financial strength and potential long-term promise amidst current market conditions.
Top 10 Penny Stocks In Canada
Name | Share Price | Market Cap | Financial Health Rating |
Alvopetro Energy (TSXV:ALV) | CA$4.60 | CA$168.17M | ★★★★★★ |
Mandalay Resources (TSX:MND) | CA$4.80 | CA$450.76M | ★★★★★★ |
NTG Clarity Networks (TSXV:NCI) | CA$2.05 | CA$86.42M | ★★★★★☆ |
Findev (TSXV:FDI) | CA$0.50 | CA$14.32M | ★★★★★★ |
PetroTal (TSX:TAL) | CA$0.64 | CA$586.49M | ★★★★★★ |
BluMetric Environmental (TSXV:BLM) | CA$1.08 | CA$39.87M | ★★★★★★ |
McCoy Global (TSX:MCB) | CA$2.92 | CA$79.37M | ★★★★★★ |
New Gold (TSX:NGD) | CA$4.15 | CA$3.28B | ★★★★★☆ |
NamSys (TSXV:CTZ) | CA$1.16 | CA$31.16M | ★★★★★★ |
Orezone Gold (TSX:ORE) | CA$0.82 | CA$379.19M | ★★★★★☆ |
Click here to see the full list of 936 stocks from our TSX Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
TerrAscend
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: TerrAscend Corp. is involved in the cultivation, processing, and sale of medical and adult-use cannabis across Canada and the United States, with a market cap of CA$248.75 million.
Operations: There are no specific revenue segments reported for this company.
Market Cap: CA$248.75M
TerrAscend Corp., with a market cap of CA$248.75 million, reported sales of US$306.68 million for 2024, showing a slight decrease from the previous year. Despite being unprofitable with a net loss of US$80.23 million, the company has managed to reduce its losses over five years by 3.1% annually and maintains sufficient cash runway for more than three years due to positive free cash flow growth. The stock trades at a significant discount to its estimated fair value and peers, though it faces challenges such as high debt levels and volatility in share price stability.
-
Take a closer look at TerrAscend's potential here in our financial health report.
-
Examine TerrAscend's earnings growth report to understand how analysts expect it to perform.
Rock Tech Lithium
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Rock Tech Lithium Inc. is involved in the exploration and development of lithium properties, with a market cap of CA$117.63 million.